カテゴリー： 世界, 医療/バイオ, LP Information

世界の経口新型コロナウイルス感染症ワクチン市場予測 2023年-2029年

【英語タイトル】Global Oral COVID-19 Vaccine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02560）・商品コード：LP23DC02560
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：90
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の経口新型コロナウイルス感染症ワクチン市場」は、過去の販売実績から2022年の世界の経口新型コロナウイルス感染症ワクチンの総販売量を検討し、2023年から2029年の予測される経口新型コロナウイルス感染症ワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の経口新型コロナウイルス感染症ワクチンの市場規模を掲載し、XXX百万米ドル規模の世界の経口新型コロナウイルス感染症ワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界の経口新型コロナウイルス感染症ワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の経口新型コロナウイルス感染症ワクチン市場における各社の独自のポジションをより深く理解するために、経口新型コロナウイルス感染症ワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の経口新型コロナウイルス感染症ワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。経口新型コロナウイルス感染症ワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。経口新型コロナウイルス感染症ワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。経口新型コロナウイルス感染症ワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

経口新型コロナウイルス感染症ワクチンの世界主要メーカーとしては、Pfizer、 CanSino Biologics、 Kindred Biosciences, Inc.、 Zhejiang Huahai Pharmaceutical Co.,ltd.、 Shandong Xinhua Pharmaceutical、 Kintor Pharmaceutical、 Henan Genuine Biotech Co., Ltd.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の経口新型コロナウイルス感染症ワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では経口新型コロナウイルス感染症ワクチン市場をセグメンテーションし、種類別 (錠剤、吸入式)、用途別 (大人、子供、高齢者)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：錠剤、吸入式

・用途別区分：大人、子供、高齢者

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の経口新型コロナウイルス感染症ワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見た経口新型コロナウイルス感染症ワクチン市場成長の要因は何か？
・経口新型コロナウイルス感染症ワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・経口新型コロナウイルス感染症ワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：経口新型コロナウイルス感染症ワクチンの年間販売量2018-2029、地域別現状・将来分析
・経口新型コロナウイルス感染症ワクチンの種類別セグメント：錠剤、吸入式
・経口新型コロナウイルス感染症ワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・経口新型コロナウイルス感染症ワクチンの用途別セグメント：大人、子供、高齢者
・経口新型コロナウイルス感染症ワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の経口新型コロナウイルス感染症ワクチン市場
・企業別のグローバル経口新型コロナウイルス感染症ワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の経口新型コロナウイルス感染症ワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別の経口新型コロナウイルス感染症ワクチン販売価格
・主要企業の経口新型コロナウイルス感染症ワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

経口新型コロナウイルス感染症ワクチンの地域別レビュー
・地域別の経口新型コロナウイルス感染症ワクチン市場規模2018-2023：年間販売量、売上
・主要国別の経口新型コロナウイルス感染症ワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカの経口新型コロナウイルス感染症ワクチン販売の成長
・アジア太平洋の経口新型コロナウイルス感染症ワクチン販売の成長
・ヨーロッパの経口新型コロナウイルス感染症ワクチン販売の成長
・中東・アフリカの経口新型コロナウイルス感染症ワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別の経口新型コロナウイルス感染症ワクチン販売量、売上（2018-2023）
・南北アメリカの経口新型コロナウイルス感染症ワクチンの種類別販売量
・南北アメリカの経口新型コロナウイルス感染症ワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の経口新型コロナウイルス感染症ワクチン販売量、売上（2018-2023）
・アジア太平洋の経口新型コロナウイルス感染症ワクチンの種類別販売量
・アジア太平洋の経口新型コロナウイルス感染症ワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の経口新型コロナウイルス感染症ワクチン販売量、売上（2018-2023）
・ヨーロッパの経口新型コロナウイルス感染症ワクチンの種類別販売量
・ヨーロッパの経口新型コロナウイルス感染症ワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の経口新型コロナウイルス感染症ワクチン販売量、売上（2018-2023）
・中東・アフリカの経口新型コロナウイルス感染症ワクチンの種類別販売量
・中東・アフリカの経口新型コロナウイルス感染症ワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・経口新型コロナウイルス感染症ワクチンの製造コスト構造分析
・経口新型コロナウイルス感染症ワクチンの製造プロセス分析
・経口新型コロナウイルス感染症ワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・経口新型コロナウイルス感染症ワクチンの主要なグローバル販売業者
・経口新型コロナウイルス感染症ワクチンの主要なグローバル顧客

地域別の経口新型コロナウイルス感染症ワクチン市場予測レビュー
・地域別の経口新型コロナウイルス感染症ワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・経口新型コロナウイルス感染症ワクチンの種類別市場規模予測
・経口新型コロナウイルス感染症ワクチンの用途別市場規模予測

主要企業分析
Pfizer、 CanSino Biologics、 Kindred Biosciences, Inc.、 Zhejiang Huahai Pharmaceutical Co.,ltd.、 Shandong Xinhua Pharmaceutical、 Kintor Pharmaceutical、 Henan Genuine Biotech Co., Ltd.
・企業情報
・経口新型コロナウイルス感染症ワクチン製品
・経口新型コロナウイルス感染症ワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Oral COVID-19 Vaccine market size is projected to grow from US$ 1173.9 million in 2022 to US$ 1707.4 million in 2029; it is expected to grow at a CAGR of 5.5% from 2023 to 2029.
United States market for Oral COVID-19 Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oral COVID-19 Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oral COVID-19 Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oral COVID-19 Vaccine players cover Pfizer, CanSino Biologics, Kindred Biosciences, Inc., Zhejiang Huahai Pharmaceutical Co.,ltd., Shandong Xinhua Pharmaceutical, Kintor Pharmaceutical and Henan Genuine Biotech Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Oral COVID-19 Vaccine Industry Forecast” looks at past sales and reviews total world Oral COVID-19 Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral COVID-19 Vaccine sales for 2023 through 2029. With Oral COVID-19 Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral COVID-19 Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Oral COVID-19 Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral COVID-19 Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral COVID-19 Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral COVID-19 Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral COVID-19 Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral COVID-19 Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablet Type
Inhalable Type
Segmentation by application
Adults
Children
Elderly
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer
CanSino Biologics
Kindred Biosciences, Inc.
Zhejiang Huahai Pharmaceutical Co.,ltd.
Shandong Xinhua Pharmaceutical
Kintor Pharmaceutical
Henan Genuine Biotech Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral COVID-19 Vaccine market?
What factors are driving Oral COVID-19 Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral COVID-19 Vaccine market opportunities vary by end market size?
How does Oral COVID-19 Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral COVID-19 Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oral COVID-19 Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oral COVID-19 Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Oral COVID-19 Vaccine Segment by Type
2.2.1 Tablet Type
2.2.2 Inhalable Type
2.3 Oral COVID-19 Vaccine Sales by Type
2.3.1 Global Oral COVID-19 Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Oral COVID-19 Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oral COVID-19 Vaccine Sale Price by Type (2018-2023)
2.4 Oral COVID-19 Vaccine Segment by Application
2.4.1 Adults
2.4.2 Children
2.4.3 Elderly
2.5 Oral COVID-19 Vaccine Sales by Application
2.5.1 Global Oral COVID-19 Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Oral COVID-19 Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oral COVID-19 Vaccine Sale Price by Application (2018-2023)
3 Global Oral COVID-19 Vaccine by Company
3.1 Global Oral COVID-19 Vaccine Breakdown Data by Company
3.1.1 Global Oral COVID-19 Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Oral COVID-19 Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Oral COVID-19 Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Oral COVID-19 Vaccine Revenue by Company (2018-2023)
3.2.2 Global Oral COVID-19 Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Oral COVID-19 Vaccine Sale Price by Company
3.4 Key Manufacturers Oral COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral COVID-19 Vaccine Product Location Distribution
3.4.2 Players Oral COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral COVID-19 Vaccine by Geographic Region
4.1 World Historic Oral COVID-19 Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Oral COVID-19 Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oral COVID-19 Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oral COVID-19 Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Oral COVID-19 Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oral COVID-19 Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oral COVID-19 Vaccine Sales Growth
4.4 APAC Oral COVID-19 Vaccine Sales Growth
4.5 Europe Oral COVID-19 Vaccine Sales Growth
4.6 Middle East & Africa Oral COVID-19 Vaccine Sales Growth
5 Americas
5.1 Americas Oral COVID-19 Vaccine Sales by Country
5.1.1 Americas Oral COVID-19 Vaccine Sales by Country (2018-2023)
5.1.2 Americas Oral COVID-19 Vaccine Revenue by Country (2018-2023)
5.2 Americas Oral COVID-19 Vaccine Sales by Type
5.3 Americas Oral COVID-19 Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral COVID-19 Vaccine Sales by Region
6.1.1 APAC Oral COVID-19 Vaccine Sales by Region (2018-2023)
6.1.2 APAC Oral COVID-19 Vaccine Revenue by Region (2018-2023)
6.2 APAC Oral COVID-19 Vaccine Sales by Type
6.3 APAC Oral COVID-19 Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral COVID-19 Vaccine by Country
7.1.1 Europe Oral COVID-19 Vaccine Sales by Country (2018-2023)
7.1.2 Europe Oral COVID-19 Vaccine Revenue by Country (2018-2023)
7.2 Europe Oral COVID-19 Vaccine Sales by Type
7.3 Europe Oral COVID-19 Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral COVID-19 Vaccine by Country
8.1.1 Middle East & Africa Oral COVID-19 Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oral COVID-19 Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Oral COVID-19 Vaccine Sales by Type
8.3 Middle East & Africa Oral COVID-19 Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral COVID-19 Vaccine
10.3 Manufacturing Process Analysis of Oral COVID-19 Vaccine
10.4 Industry Chain Structure of Oral COVID-19 Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral COVID-19 Vaccine Distributors
11.3 Oral COVID-19 Vaccine Customer
12 World Forecast Review for Oral COVID-19 Vaccine by Geographic Region
12.1 Global Oral COVID-19 Vaccine Market Size Forecast by Region
12.1.1 Global Oral COVID-19 Vaccine Forecast by Region (2024-2029)
12.1.2 Global Oral COVID-19 Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral COVID-19 Vaccine Forecast by Type
12.7 Global Oral COVID-19 Vaccine Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Oral COVID-19 Vaccine Product Portfolios and Specifications
13.1.3 Pfizer Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 CanSino Biologics
13.2.1 CanSino Biologics Company Information
13.2.2 CanSino Biologics Oral COVID-19 Vaccine Product Portfolios and Specifications
13.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CanSino Biologics Main Business Overview
13.2.5 CanSino Biologics Latest Developments
13.3 Kindred Biosciences, Inc.
13.3.1 Kindred Biosciences, Inc. Company Information
13.3.2 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolios and Specifications
13.3.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Kindred Biosciences, Inc. Main Business Overview
13.3.5 Kindred Biosciences, Inc. Latest Developments
13.4 Zhejiang Huahai Pharmaceutical Co.,ltd.
13.4.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
13.4.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
13.4.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Main Business Overview
13.4.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Latest Developments
13.5 Shandong Xinhua Pharmaceutical
13.5.1 Shandong Xinhua Pharmaceutical Company Information
13.5.2 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
13.5.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shandong Xinhua Pharmaceutical Main Business Overview
13.5.5 Shandong Xinhua Pharmaceutical Latest Developments
13.6 Kintor Pharmaceutical
13.6.1 Kintor Pharmaceutical Company Information
13.6.2 Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
13.6.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Kintor Pharmaceutical Main Business Overview
13.6.5 Kintor Pharmaceutical Latest Developments
13.7 Henan Genuine Biotech Co., Ltd.
13.7.1 Henan Genuine Biotech Co., Ltd. Company Information
13.7.2 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
13.7.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Henan Genuine Biotech Co., Ltd. Main Business Overview
13.7.5 Henan Genuine Biotech Co., Ltd. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Oral COVID-19 Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oral COVID-19 Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablet Type
Table 4. Major Players of Inhalable Type
Table 5. Global Oral COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Oral COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Oral COVID-19 Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Oral COVID-19 Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Oral COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Oral COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Oral COVID-19 Vaccine Revenue by Application (2018-2023)
Table 13. Global Oral COVID-19 Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Oral COVID-19 Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Oral COVID-19 Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Oral COVID-19 Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Oral COVID-19 Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Oral COVID-19 Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Oral COVID-19 Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Oral COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 21. Players Oral COVID-19 Vaccine Products Offered
Table 22. Oral COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oral COVID-19 Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Oral COVID-19 Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Oral COVID-19 Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Oral COVID-19 Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Oral COVID-19 Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Oral COVID-19 Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Oral COVID-19 Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Oral COVID-19 Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Oral COVID-19 Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Oral COVID-19 Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Oral COVID-19 Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Oral COVID-19 Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Oral COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Oral COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Oral COVID-19 Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Oral COVID-19 Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Oral COVID-19 Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Oral COVID-19 Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Oral COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Oral COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Oral COVID-19 Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Oral COVID-19 Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Oral COVID-19 Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Oral COVID-19 Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Oral COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Oral COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Oral COVID-19 Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Oral COVID-19 Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Oral COVID-19 Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Oral COVID-19 Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Oral COVID-19 Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Oral COVID-19 Vaccine
Table 58. Key Market Challenges & Risks of Oral COVID-19 Vaccine
Table 59. Key Industry Trends of Oral COVID-19 Vaccine
Table 60. Oral COVID-19 Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Oral COVID-19 Vaccine Distributors List
Table 63. Oral COVID-19 Vaccine Customer List
Table 64. Global Oral COVID-19 Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Oral COVID-19 Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Oral COVID-19 Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Oral COVID-19 Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Oral COVID-19 Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Oral COVID-19 Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Oral COVID-19 Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Oral COVID-19 Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Oral COVID-19 Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Oral COVID-19 Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Oral COVID-19 Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Oral COVID-19 Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Oral COVID-19 Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Oral COVID-19 Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 80. Pfizer Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. CanSino Biologics Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CanSino Biologics Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 85. CanSino Biologics Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. CanSino Biologics Main Business
Table 87. CanSino Biologics Latest Developments
Table 88. Kindred Biosciences, Inc. Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 90. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Kindred Biosciences, Inc. Main Business
Table 92. Kindred Biosciences, Inc. Latest Developments
Table 93. Zhejiang Huahai Pharmaceutical Co.,ltd. Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 95. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Zhejiang Huahai Pharmaceutical Co.,ltd. Main Business
Table 97. Zhejiang Huahai Pharmaceutical Co.,ltd. Latest Developments
Table 98. Shandong Xinhua Pharmaceutical Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 100. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Shandong Xinhua Pharmaceutical Main Business
Table 102. Shandong Xinhua Pharmaceutical Latest Developments
Table 103. Kintor Pharmaceutical Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 105. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Kintor Pharmaceutical Main Business
Table 107. Kintor Pharmaceutical Latest Developments
Table 108. Henan Genuine Biotech Co., Ltd. Basic Information, Oral COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolios and Specifications
Table 110. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Henan Genuine Biotech Co., Ltd. Main Business
Table 112. Henan Genuine Biotech Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Oral COVID-19 Vaccine
Figure 2. Oral COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral COVID-19 Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oral COVID-19 Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oral COVID-19 Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablet Type
Figure 10. Product Picture of Inhalable Type
Figure 11. Global Oral COVID-19 Vaccine Sales Market Share by Type in 2022
Figure 12. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Oral COVID-19 Vaccine Consumed in Adults
Figure 14. Global Oral COVID-19 Vaccine Market: Adults (2018-2023) & (K Units)
Figure 15. Oral COVID-19 Vaccine Consumed in Children
Figure 16. Global Oral COVID-19 Vaccine Market: Children (2018-2023) & (K Units)
Figure 17. Oral COVID-19 Vaccine Consumed in Elderly
Figure 18. Global Oral COVID-19 Vaccine Market: Elderly (2018-2023) & (K Units)
Figure 19. Global Oral COVID-19 Vaccine Sales Market Share by Application (2022)
Figure 20. Global Oral COVID-19 Vaccine Revenue Market Share by Application in 2022
Figure 21. Oral COVID-19 Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Oral COVID-19 Vaccine Sales Market Share by Company in 2022
Figure 23. Oral COVID-19 Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Oral COVID-19 Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Oral COVID-19 Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Oral COVID-19 Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Oral COVID-19 Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Oral COVID-19 Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Oral COVID-19 Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Oral COVID-19 Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Oral COVID-19 Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Oral COVID-19 Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Oral COVID-19 Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Oral COVID-19 Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Oral COVID-19 Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Oral COVID-19 Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Oral COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Oral COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Oral COVID-19 Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Oral COVID-19 Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Oral COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Oral COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Oral COVID-19 Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Oral COVID-19 Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Oral COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Oral COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Oral COVID-19 Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Oral COVID-19 Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Oral COVID-19 Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral COVID-19 Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Oral COVID-19 Vaccine
Figure 74. Industry Chain Structure of Oral COVID-19 Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Oral COVID-19 Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Oral COVID-19 Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Oral COVID-19 Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Oral COVID-19 Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Oral COVID-19 Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Oral COVID-19 Vaccine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の経口新型コロナウイルス感染症ワクチン市場予測 2023年-2029年] (コード：LP23DC02560)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の経口新型コロナウイルス感染症ワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のmRNA新型コロナウイルスワクチン市場予測 2023年-2029年
  • 世界の経口ワクチン投与市場予測 2023年-2029年
  • 世界の吸入用組換え新型コロナウイルスワクチン市場予測 2023年-2029年
  • 世界の医薬品内服液用PETボトル市場予測 2023年-2029年
  • 世界の医療用内服薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆